Cited by 209Heart Failure Treatment and ManagementCardiovascular Function and Risk FactorsCardiovascular and exercise physiology

Cardiovascular Phenotype in HFpEF Patients With or Without Diabetes

Open access
Lindman, Brian R., Dávila-Román, Victor G., Mann, Douglas L., McNulty, Steven, Semigran, Marc J., Lewis, Gregory D., de las Fuentes, Lisa, Joseph, Susan M. +3 more·2014·Journal of the American College of Cardiology

Abstract

Background The RELAX (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Heart Failure with Preserved Ejection Fraction) study was a multicenter, randomized trial of sildenafil versus placebo in heart failure with preserved ejection fraction (HFpEF) with rigorous entry criteria and extensive phenotypic characterization of participants.Objectives The aim of this study was to characterize clinical features, exercise capacity, and outcomes in patients with HFpEF with or without diabetes and gain insight into contributing pathophysiological mechanisms.Methods The RELAX study enrolled 216 stable outpatients with heart failure, an ejection fraction ≥ 50%, increased natriuretic peptide or intracardiac pressures, and reduced exercise capacity. Prospectively collected data included echocardiography, cardiac magnetic resonance, a comprehensive biomarker panel, exercise testing, and clinical events over 6 months.Results Compared with nondiabetic patients (n = 123), diabetic HFpEF patients (n = 93) were younger, more obese, and more often male and had a higher prevalence of hypertension, renal dysfunction, pulmonary disease, and vascular disease (p < 0.05 for all). Uric acid, C-reactive protein, galectin-3, carboxy-terminal telopeptide of collagen type I, and endothelin-1 levels were higher in diabetic patients (p < 0.05 for all). Diabetic patients had more ventricular hypertrophy, but systolic and diastolic ventricular function parameters were similar in diabetic and nondiabetic patients except for a trend toward higher filling pressures (E/e') in diabetic patients. Diabetic patients had worse maximal (peak oxygen uptake) and submaximal (6-min walk distance) exercise capacity (p < 0.01 for both). Diabetic patients were more likely to have been hospitalized for heart failure in the year before study entry (47% vs. 28%, p = 0.004) and had a higher incidence of cardiac or renal hospitalization at 6 months after enrollment (23.7% vs. 4.9%, p < 0.001).Conclusions HFpEF patients with diabetes are at increased risk of hospitalization and have reduced exercise capacity. Multimorbidity, impaired chronotropic reserve, left ventricular hypertrophy, and activation of inflammatory, pro-oxidative, vasoconstrictor, and profibrotic pathways may contribute to adverse outcomes in HFpEF patients with diabetes. (Evaluating the Effectiveness of Sildenafil at Improving Health Outcomes and Exercise Ability in People With Diastolic Heart Failure [The RELAX Study]; NCT00763867).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2014.05.030

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lindman, B. R., Dávila-Román, V. G., Mann, D. L., McNulty, S., Semigran, M. J., Lewis, G. D., de las Fuentes, L., Joseph, S. M., Vader, J., Hernandez, A. F., & Redfield, M. M.
Affiliations
  • Washington University in St. Louis (US)
  • Duke University (US)
  • Harvard University (US)
  • Mayo Clinic (US)
Corresponding author
Lindman, Brian R.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2014-08
Volume
64
Issue
6
Pages
541-549
ISSN
0735-1097 (ISSN-L)
OpenAlex
W1848919668
Cited by
209
References
42
Citations by year
2026: 7 · 2025: 20 · 2024: 28 · 2023: 12 · 2022: 20 · 2021: 26 · 2020: 23 · 2019: 18 · 2018: 11 · 2017: 14 · 2016: 14 · 2015: 15 · 2014: 1
FWCI
10.08
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (KL2TR000450, UL1TR000448)
  • National Heart, Lung, and Blood Institute (U10HL084904, R01HL105418, U10HL110262, U01HL084907, U10HL110309, U10HL084907, U10HL110337, K23HL116660)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Health Sciences › Medicine › Complementary and alternative medicine › Cardiovascular and exercise physiology
Keywords
heart failure with preserved ejection fraction, diabetes mellitus, cardiovascular phenotype, exercise capacity, peak oxygen uptake, 6-minute walk distance, left ventricular hypertrophy, multimorbidity, inflammatory markers, endothelin-1, galectin-3, uric acid, C-reactive protein, heart failure hospitalization, sildenafil, diastolic dysfunction, myocardial fibrosis
MeSH terms
Sildenafil Citrate, Aged, Diabetes Mellitus, Female, Heart Failure, Humans, Male, Middle Aged, Phenotype, Piperazines, Prospective Studies, Purines, Stroke Volume, Sulfones, Cohort Studies, Phosphodiesterase 5 Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review